IL-33 Reduces Saturated Fatty Acid Accumulation in Mouse Atherosclerotic Foci
Authors:
- Yukako HosomiYHYukako Hosomi
- Takuro OkamuraTOTakuro Okamura
- Kimiko SakaiKSKimiko Sakai
- Hiroki YugeHYHiroki Yuge
- Takashi YoshimuraTYTakashi Yoshimura
- Saori MajimaSMSaori Majima
- Hiroshi OkadaHiroshi Okada
- Takafumi SenmaruTSTakafumi Senmaru
- Emi UshigomeEUEmi Ushigome
- Naoko NakanishiNNNaoko Nakanishi
- Takashi SatohTSTakashi Satoh
Open Access
Abstract
The cellular and molecular mechanisms of atherosclerosis are still unclear. Type 2 innate lymphocytes (ILC2) exhibit anti-inflammatory properties and protect against atherosclerosis. This study aimed to elucidate the pathogenesis of atherosclerosis development using atherosclerosis model mice (ApoE KO mice) and mice deficient in IL-33 receptor ST2 (ApoEST2 DKO mice). Sixteen-week-old male ApoE KO and ApoEST2 DKO mice were subjected to an 8-week regimen of a high-fat, high-sucrose diet. Atherosclerotic foci were assessed histologically at the aortic valve ring. Chronic inflammation was assessed using flow cytometry and real-time polymerase chain reaction. In addition, saturated fatty acids (palmitic acid) and IL-33 were administered to human aortic endothelial cells (HAECs) to assess fatty acid metabolism. ApoEST2 DKO mice with attenuated ILC2 had significantly worse atherosclerosis than ApoE KO mice. The levels of saturated fatty acids, including palmitic acid, were significantly elevated in the arteries and serum of ApoEST2 DKO mice. Furthermore, on treating HAECs with saturated fatty acids with or without IL-33, the Oil Red O staining area significantly decreased in the IL-33-treated group compared to that in the non-treated group. IL-33 potentially prevented the accumulation of saturated fatty acids within atherosclerotic foci.Keywords
Funding Information
- Japan Society for the Promotion of Science (22K08108)
This publication has 47 references indexed in Scilit:
- Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosisNature Reviews Cardiology, 2021
- Immunologic mechanisms in asthmaSeminars in Immunology, 2019
- ST2 and the ST2/IL-33 signalling pathway–biochemistry and pathophysiology in animal models and humansClinica Chimica Acta, 2019
- Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesityNature, 2014
- oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4Journal of Molecular and Cellular Cardiology, 2014
- Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient miceCardiovascular Pathology, 2012
- The IL-33/ST2 pathway — A new therapeutic target in cardiovascular diseasePharmacology & Therapeutics, 2011
- 5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α–Induced Hepatocyte Damage in Hyperlipidemia-Prone Apoe-Null MiceHepatology, 2009
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001